Worst set of numbers in Q2. Company is bleeding money and faith of innocent retail investors. No signs of recovery in short to medium term. Those who are trapped at higher levels must exit and invest the leftover in a good midcap company available at great discounts.
| Subscribe To Our Free Newsletter |
